NAV as of 21 Oct 2026, 12:00 AM UTC
$1.73 (2.98%)
Year-To-Date Change
-69.63%
LSE
Borsa Italiana
Capital at risk. NAV calculated by Leverage Shares. For more information on the calculation please click here
The Leverage Shares -3x Short Eli Lilly (LLY) ETP (ISIN XS3068786972) is an exchange traded product (ETP) that seeks to deliver minus three times (-3x) the daily performance of Eli Lilly and Company. It achieves leverage through margin borrowing and has physical ownership of the underlying, so it does not use swaps or other derivatives to achieve its exposure, and it does not have credit risk. Exposure is rebalanced daily, and an intraday rebalance mechanism ("airbag") is designed to cushion the largest intra-day moves, triggering at 16.67%. You cannot lose more than the amount you invest. The Leverage Shares -3x Short Eli Lilly (LLY) ETP has an annual management fee of 0.75% and is listed on the following exchanges: London Stock Exchange, Borsa Italiana. It is designed for short term trading and should be monitored daily.
To seek daily investment results, before fees and expenses, that correspond to -300% (-3x) the daily performance of the underlying stock (LLY).
Sophisticated investors and active traders seeking to express short-term bearish views or tactically hedge positions, via inverse exposure and without a margin account.
*However, these are complex products.
Value of Underlying Assets
$-241,443
or -190 shares of LLY
AUM
$80,455
or 46,500 shares of LLYS
Liabilities
$321,897
Passported Countries:
United Kingdom
Italy
Germany
France
Spain
Netherlands
Ireland
Poland
Belgium
Sweden
Norway
Austria
* The information on this website regarding UK Fund Reporting Status is accurate as of the stated effective date (the "Effective Date"). Leverage Shares makes no representation or warranty that such information will remain accurate, complete or current thereafter, assumes no obligation to update it, and, to the fullest extent permitted by applicable law, accepts no responsibility or liability for any inaccuracies or omissions arising after the Effective Date.
Market Insights
